| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |